{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:11:20Z","timestamp":1791263480259,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.expneurol.2011.08.015","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T08:51:01Z","timestamp":1314867061000},"page":"149-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study"],"prefix":"10.1016","volume":"232","author":[{"given":"Kazumoto","family":"Shibuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihito","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagiri","family":"Isose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichi","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Fujimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.08.015_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nurt.2008.08.002","article-title":"ALS drug development: reflections from the past and a way forward","volume":"5","author":"Aggarwal","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/brain\/118.1.217","article-title":"Axonal ion channel dysfunction in amyotrophic lateral sclerosis","volume":"118","author":"Bostock","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1212\/WNL.47.4_Suppl_2.71S","article-title":"Natural history of ALS: symptoms, strength, pulmonary function, and disability","volume":"47","author":"Brooks","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0306-9877(94)90160-0","article-title":"Amyotrophic lateral sclerosis: hypothetical pathogenesis","volume":"42","author":"Brown","year":"1994","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0733-8619(18)30931-9","article-title":"Amyotrophic lateral sclerosis. Its natural history","volume":"5","author":"Caroscio","year":"1987","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0030","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0035","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awg153","article-title":"Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination","volume":"126","author":"Craner","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1097-4598(199803)21:3<336::AID-MUS7>3.0.CO;2-B","article-title":"Fasciculation potentials: a study of amyotrophic lateral sclerosis and other neurogenic disorders","volume":"21","author":"de Carvalho","year":"1998","journal-title":"Muscle Nerve"},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2011.08.015_bb0045","first-page":"S43","article-title":"Pathophysiological significance of fasciculations in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor","author":"de Carvalho","year":"2000","journal-title":"Neuron Disord."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1600-0404.1967.tb05756.x","article-title":"Sensory and motor conduction in motor neurone disease","volume":"43","author":"Ertekin","year":"1967","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.14.1.31","article-title":"Sensory nerve conduction in amyotrophic lateral sclerosis","volume":"14","author":"Fincham","year":"1964","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0060","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1750-3639.2008.00163.x","article-title":"Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations","volume":"19","author":"Freeman","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1989.tb12512.x","article-title":"Neurotoxicity at the N-methyl-d-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease","volume":"568","author":"Henneberry","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1523\/JNEUROSCI.1484-03.2004","article-title":"Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation","volume":"24","author":"Ishibashi","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.20379","article-title":"Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis","volume":"57","author":"Jiang","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0085","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awl024","article-title":"Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage","volume":"129","author":"Kanai","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","article-title":"Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration","volume":"34","author":"LaMonte","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0105","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mus.880171102","article-title":"The origin of muscle fasciculations and cramps","volume":"17","author":"Layzer","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0110","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00000542-199205000-00023","article-title":"Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission","volume":"76","author":"Mantz","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0115","first-page":"555","article-title":"Therapeutic potential of neuronal two-pore domain potassium-channel modulators","volume":"8","author":"Mathie","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0120","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/brain\/121.5.851","article-title":"Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis","volume":"121","author":"Mogyoros","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/17482960903452283","article-title":"Voltage gated potassium channel antibodies in amyotrophic lateral sclerosis","volume":"11","author":"Nwosu","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0135","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/01.wnl.0000261045.57095.56","article-title":"Implications of ALS focality: rostral\u2013caudal distribution of lower motor neuron loss postmortem","volume":"68","author":"Ravits","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.43.7.1316","article-title":"The natural history of amyotrophic lateral sclerosis","volume":"43","author":"Ringel","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)36856-9","article-title":"Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels","volume":"282","author":"Song","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4236\/nm.2011.22010","article-title":"Motor neuron disease associated with voltage-gated potassium channel antibodies","volume":"2","author":"Thompson","year":"2011","journal-title":"Neurosci. Med."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000089620","article-title":"Excitotoxicity and amyotrophic lateral sclerosis","volume":"2","author":"Van Damme","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.expneurol.2011.08.015_bb0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Van Den Bosch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2011.08.015_bb0165","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.clinph.2006.04.016","article-title":"Axonal excitability properties in amyotrophic lateral sclerosis","volume":"117","author":"Vucic","year":"2006","journal-title":"Clin. Neurophysiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:43:48Z","timestamp":1758001428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0014488611002809"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.08.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}